Zobrazeno 1 - 10
of 184
pro vyhledávání: '"E. Venkatraman"'
Autor:
J. Dupont, C. Aghajanian, G. Andrea, M. Lovegren, S. Chuai, E. Venkatraman, M. Hensley, S. Anderson, D. Spriggs, P. Sabbatini
Publikováno v:
International Journal of Gynecologic Cancer. 16:68-73
A variety of agents have emerged to treat patients with recurrent epithelial ovarian cancer (EOC). Most patients receive both topotecan (T) and liposomal doxorubicin (D); however, there are no data regarding the benefit of a sequence—D followed by
Autor:
Michael J. Zelefsky, Leah Ben-Porat, Steven A. Leibel, Zvi Fuks, H.M. Chan, Howard I. Scher, E. Venkatraman, Paul A. Fearn
Publikováno v:
Journal of Clinical Oncology. 23:826-831
Purpose To identify predictors of distant metastases (DM) among patients who develop an isolated prostate-specific antigen (PSA) relapse after definitive external-beam radiotherapy for clinically localized prostate cancer. Materials and Methods A tot
Autor:
Theresa Wolfe, C. Clifton Ling, Zvi Fuks, Michael J. Zelefsky, G.J. Kutcher, Chandra Burman, Steven A. Leibel, E. Venkatraman
Publikováno v:
Radiology. 209:169-174
To determine the long-term effects of 75.6- and 81.0-Gy doses of three-dimensional conformal radiation therapy in a dose-escalation study in patients with stage T2c-T3 prostatic cancer.Fifty patients received an initial 75.6-Gy dose, and the dose in
Autor:
Mark G. Kris, Didier Cupissol, Luigi X. Cubeddu, Richard J. Gralla, Howard D. Homesley, B R N Leslie Tyson, E. Venkatraman
Publikováno v:
Cancer. 78:2193-2198
BACKGROUND Because of the predictability of significant emesis after its use, cisplatin serves as the standard emetic stimulus for trials of antiemetic drugs. To define better the incidence, severity, and pattern of emesis that follows cisplatin, fac
Publikováno v:
2012 International Conference on Computing, Electronics and Electrical Technologies (ICCEET).
Nowadays due to increase in size, increasing demand and complexity in interconnected power system, load frequency control has become more significant. In general Proportional Integral [PI] controllers are used for Load frequency Control, which is gen
Autor:
E. Venkatraman, William Pao, M. Ladanyi, L.B. Schwartz, Valerie W. Rusch, Binsheng Zhao, Mark G. Kris, Maureen F. Zakowski, Naiyer A. Rizvi, Robert T. Heelan
Publikováno v:
Journal of Thoracic Oncology. 2(8)
Autor:
Patricia E. Saigo, William J. Hoskins, Richard R. Barakat, Teresa Gilewski, Lois Almadrones, E. Venkatraman, Clifford A. Hudis
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 18(20)
PURPOSE: To determine the frequency of developing abnormal pathologic changes in the endometria of tamoxifen-treated women. To characterize the type of pathologic changes involved. PATIENTS AND METHODS: Between October 1991 and September 1998, 159 pa
Autor:
Richard R. Barakat, Carol L. Brown, Larry Norton, John P. Curtin, Lois Almadrones, Carol Aghajanian, William J. Hoskins, Lilian Reich, E. Venkatraman, R Waltzman, D.R. Spriggs, C O'Flaherty, D Wuest, David Fennelly, K O'Conner, F. Shapiro
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 16(5)
PURPOSE We performed a pilot phase II study to evaluate the potential for delivery of rapidly sequenced high-dose chemotherapy treatments rescued with autologous peripheral-blood progenitor cells (PBP) in patients with previously untreated, advanced
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 66:S124-S125
Autor:
C L, Finstad, K O, Lloyd, M G, Federici, C, Divgi, E, Venkatraman, R R, Barakat, R D, Finn, S M, Larson, W J, Hoskins, J L, Humm
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(8)
Our objective was to quantify the targeting of the monoclonal antibody (mAb) MX35 F(ab')2 to micrometastatic epithelial ovarian cancer. This mAb detects a Mr 95,000 glycoprotein with homogeneous distribution on 80% of ovarian tumor specimens. Six pat